Author:
Linder Andreas,Bothe Viktoria,Linder Nicolas,Schwarzlmueller Paul,Dahlström Frank,Bartenhagen Christoph,Dugas Martin,Pandey Dharmendra,Thorn-Seshold Julia,Boehmer Daniel F. R.,Koenig Lars M.,Kobold Sebastian,Schnurr Max,Raedler Johannes,Spielmann Giulia,Karimzadeh Hadi,Schmidt Andreas,Endres Stefan,Rothenfusser Simon
Abstract
Replication competent vesicular stomatitis virus (VSV) is the basis of a vaccine against Ebola and VSV strains are developed as oncolytic viruses. Both functions depend on the ability of VSV to induce adequate amounts of interferon-α/β. It is therefore important to understand how VSV triggers interferon responses. VSV activates innate immunity via retinoic acid-inducible gene I (RIG-I), a sensor for viral RNA. Our results show that VSV needs to replicate for a robust interferon response. Analysis of RIG-I-associated RNA identified a copy-back defective-interfering (DI) genome and full-length viral genomes as main trigger of RIG-I. VSV stocks depleted of DI genomes lost most of their interferon-stimulating activity. The remaining full-length genome and leader-N-read-through sequences, however, still triggered RIG-I. Awareness for DI genomes as trigger of innate immune responses will help to standardize DI genome content and to purposefully deplete or use DI genomes as natural adjuvants in VSV-based therapeutics.
Funder
Helmholtz-Gemeinschaft
Elitenetzwerk Bayern
H2020 Marie Skłodowska-Curie Actions
Else Kröner-Fresenius-Stiftung
Friedrich-Baur-Stiftung
Deutsche Forschungsgemeinschaft
Subject
Immunology,Immunology and Allergy
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献